Table 4.
Effects of cancer on psychotropic medication use
| Ages 40 to 64 | 65 and older | |||
|---|---|---|---|---|
| Females | Males | Females | Males | |
| N | N | N | N | |
| Cancer Survivors | 1,060 | 414 | 1,164 | 768 |
| Other Adults | 14,193 | 11,164 | 6,917 | 3,785 |
| Percent with any use | % | % | % | % |
| Cancer survivors (1) | 20.3 | 11.7 | 18.6 | 11.2 |
| Other adults (2) | 14.7 | 7.5 | 15.2 | 8.1 |
|
Unadjusted difference: (1)-(2) (SE) |
5.6** (1.5) |
4.2** (1.6) |
3.4** (1.3) |
3.1** (1.2) |
| Cancer-related difference | Means (SE) | Means (SE) | Means (SE) | Means (SE) |
|
Matching without chronic
Conditions |
6.1** (1.1) |
4.5** (1.7) |
2.6** (1.1) |
3.7** (1.3) |
|
Matching with chronic
Conditions |
5.3** (1.2) |
3.4** (1.7) |
1.6 (1.2) |
2.5** (1.2) |
| Mean number of purchases | ||||
| Cancer survivors (1) | 2.6 | 1.4 | 2.0 | 1.0 |
| Other adults (2) | 1.9 | 0.9 | 1.7 | 0.8 |
|
Unadjusted difference: (1)-(2) (SE) |
.7** (.3) |
.5** (.3) |
.3 (.2) |
.2 (.1) |
| Cancer-related difference | Means (SE) | Means (SE) | Means (SE) | Means (SE) |
|
Matching without chronic
conditions |
.7** (.3) |
.6* (.3) |
.1 (.2) |
.3** (.2) |
|
Matching with chronic
conditions |
.6** (.2) |
.5 (.3) |
−.1 (.2) |
.3 (.2) |
*
Significantly different from 0 at p=0.10 level.
**
Significantly different from 0 at p=0.05 level
Cancer-related difference= mean(cancer survivors) - mean(matched controls)